XML 14 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability
The following table summarizes the number of shares of common stock authorized for issuance under the 2019 Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the 2019 Plan and the number of shares of common stock available for the grant of stock-based awards under the 2019 Plan:

Common stock authorized11,000,000  
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards(1,849,578) 
Common stock available for grant of stock-based awards as of March 31, 20209,150,422  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Total equity-based compensation for the three months ended March 31, 2020 and 2019 is as follows:

 Three Months Ended March 31,
 20202019
Restricted stock$4,864  $4,617  
Stock options822  1,054  
Total$5,686  $5,671  
Schedule Of Cash Proceeds And Intrinsic Values For Stock Options Exercised
Cash proceeds and intrinsic values related to total stock options exercised during the three months ended March 31, 2020 and 2019 are as follows:

 Three Months Ended March 31,
 20202019
Proceeds from stock options exercised$874  $722  
Intrinsic value of stock options exercised$737  $329  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used The following weighted average assumptions were used for stock options granted during the three months ended March 31, 2020 and 2019:
 20202019
Volatility33.9% to 37.6%32.4% to 33.4%
Risk free interest rate0.5% to 1.6%2.4% to 2.5%
Expected life in years3.0 to 5.03.0 to 5.0
Dividend yield1.5%1.7%
Weighted average fair value$10.22$7.88
Schedule of Share-based Compensation, Stock Options, Activity
Activity relating to stock options granted under the Company’s plans during the three months ended March 31, 2020 is as follows:
 Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20202,802,000  $26.85    
Granted274,000  42.65    
Exercised(48,000) 20.55    
Forfeited(14,000) 32.02    
Outstanding at March 31, 20203,014,000  $28.36  4.1 years$136  
Exercisable at March 31, 20201,970,000  $26.98  3.7 years$131  
Schedule of Nonvested Share Activity
The following table summarizes restricted stock activity during the three months ended March 31, 2020 and 2019:

 20202019
 Number of SharesWeighted Average Fair Value at Grant DateNumber of SharesWeighted Average Fair Value at Grant Date
Outstanding at January 1,4,427,000  $19.84  5,135,000  $18.42  
Granted366,000  34.69  518,000  32.45  
Vested(219,000) 27.15  (187,000) 25.09  
Forfeited(9,000) 32.84  (11,000) 28.19  
Outstanding at March 31,4,565,000  $20.66  5,455,000  $19.48